World's Best Scientists 2026 revealed!
VIEW LIST
Joachim von Pawel

D-Index & Metrics

Medicine

D-Index
77
Citations
45509
World Ranking
18230
National Ranking
9092

Joachim von Pawel publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Joachim von Pawel sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 286 publications — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Joachim von Pawel D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Joachim von Pawel sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 77 D-Index — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Joachim von Pawel is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on the field of Medicine with a particular concentration on Oncology and Pulmonary and Respiratory Medicine. Additional subfields include Molecular Biology, Surgery, and Epidemiology, reflecting a broad interdisciplinary approach within biomedical sciences.

Their work encompasses a variety of topics, notably in lung cancer research and treatment, as well as studies related to cholangiocarcinoma and gallbladder cancer. Specific research themes include:

  • Lung Cancer Research Studies
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Diagnosis and Treatment
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Glycosylation and Glycoproteins Research
  • RNA modifications and cancer
  • Neuroendocrine Tumor Research Advances

Their frequently published work appears mainly in the following venues:

  • Journal of Clinical Oncology (2 publications)
  • Tumor Biology (2 publications)
  • Diagnostics (1 publication)
  • UNC Libraries (1 publication)

Recent publications provide insights into lung cancer treatment protocols, biomarkers, and diagnostic approaches. These include:

  • Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non-Small-Cell Lung Cancer, 2023, Journal of Clinical Oncology
  • Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy, 2023, Journal of Clinical Oncology
  • Soluble High Mobility Group Box 1 (HMGB1) Is a Promising Biomarker for Prediction of Therapy Response and Prognosis in Advanced Lung Cancer Patients, 2021, Diagnostics
  • Improvement of differential diagnosis of lung cancer by use of multiple protein tumor marker combinations, 2024, Tumor Biology
  • Lack of clinical utility of serum macrophage migration inhibitory factor (MIF) for monitoring therapy response and estimating prognosis in advanced lung cancer, 2023, Tumor Biology

Joachim von Pawel collaborates frequently with several researchers in the oncology field. Notable frequent co-authors include Stefan Holdenrieder, Christian Manegold, U. Gatzemeier, Filippo de Marinis, and Alexander Rupp.

Best Publications

  • Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial.

    Achim Rittmeyer;Fabrice Barlesi;Daniel Waterkamp;Keunchil Park

  • Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

    Giorgio Vittorio Scagliotti;Purvish Parikh;Joachim von Pawel;Bonne Biesma

  • Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy

    Nasser Hanna;Frances A. Shepherd;Frank V. Fossella;Jose R. Pereira

  • Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

    Nick Thatcher;Alex Chang;Purvish Parikh;José Rodrigues Pereira

  • Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1

    Giuseppe Giaccone;Roy S. Herbst;Christian Manegold;Giorgio Scagliotti

  • Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL

    Martin Reck;Joachim von Pawel;Petr Zatloukal;Rodryg Ramlau

  • Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial.

    Robert Pirker;Jose R. Pereira;Aleksandra Szczesna;Joachim von Pawel

  • Randomized, Multinational, Phase III Study of Docetaxel Plus Platinum Combinations Versus Vinorelbine Plus Cisplatin for Advanced Non–Small-Cell Lung Cancer: The TAX 326 Study Group

    Frank Fossella;Jose R. Pereira;Joachim von Pawel;Anna Pluzanska

  • Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial

    Ulrich Gatzemeier;Anna Pluzanska;Aleksandra Szczesna;Eckhard Kaukel

  • Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer

    Joachim von Pawel;Joan H. Schiller;Frances A. Shepherd;Scott Z. Fields

  • Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial

    Martin Reck;Rolf Kaiser;Anders Mellemgaard;Jean-Yves Douillard

  • Phase III Trial of Gemcitabine Plus Cisplatin Versus Cisplatin Alone in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer

    Alan B. Sandler;J. Nemunaitis;C. Denham;J. Von Pawel

  • Overall survival with cisplatin–gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)

    M. Reck;J Von Pawel;P. Zatloukal;R. Ramlau

  • EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study

    Robert Pirker;Jose R. Pereira;Joachim Von Pawel;Maciej Krzakowski

  • Phase III Study of Carboplatin and Paclitaxel Alone or With Sorafenib in Advanced Non–Small-Cell Lung Cancer

    Giorgio Scagliotti;Silvia Novello;Joachim von Pawel;Martin Reck

  • Symptom Improvement in Lung Cancer Patients Treated With Erlotinib: Quality of Life Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21

    Andrea Bezjak;Dongsheng Tu;Lesley Seymour;Gary Clark

  • Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non–Small-Cell Lung Cancer

    Lecia V. Sequist;Joachim von Pawel;Edward G. Garmey;Wallace L. Akerley

  • Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer.

    John R. Eckardt;Joachim von Pawel;Jean-Louis Pujol;Zsolt Papai

  • Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non–Small-Cell Lung Cancer

    Ramaswamy Govindan;Aleksandra Szczesna;Myung Ju Ahn;Claus Peter Schneider

  • Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non–Small-Cell Lung Cancer

    Primo N Lara;Jean Yves Douillard;Kazuhiko Nakagawa;Joachim Von Pawel

Frequent Co-Authors

Martin Reck
Martin Reck LungenClinic Grosshansdorf
Giorgio V. Scagliotti
Giorgio V. Scagliotti University of Turin
Silvia Novello
Silvia Novello University of Turin
Igor Bondarenko
Igor Bondarenko Ministry of Internal Affairs
Jean-Yves Douillard
Jean-Yves Douillard European Society for Medical Oncology
Filippo De Marinis
Filippo De Marinis European Institute of Oncology
Fabrice Barlesi
Fabrice Barlesi Institut Gustave Roussy
Johan Vansteenkiste
Johan Vansteenkiste KU Leuven
Kenneth J. O'Byrne
Kenneth J. O'Byrne Queensland University of Technology
David R. Spigel
David R. Spigel Sarah Cannon Research Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA opens doors to a wide range of online degrees and healthcare career pathways. Many students begin their journey as registered nurses and later consider further specializations. For those aiming to become a family nurse practitioner without stepping away from their current roles, rn to fnp programs offer a flexible bridge to advanced practice.

An increasing number of students are also drawn to fields like nutrition. If you are passionate about promoting health and wellness, an online nutritionist degree can be a rewarding path and often complements pre-med and allied health studies.

For nurses seeking to expand their qualifications, some universities now offer online rn to bsn no clinicals programs, making it even more convenient for working professionals to upgrade their skills without extra on-site commitments.

Hospital management is another in-demand pathway. If you are a working adult exploring the administrative side of healthcare, you might wonder whats the best online mha program for working adults. These programs are designed to fit busy schedules while offering essential leadership and management training.

Best Scientists Citing Joachim von Pawel

Martin Reck

Martin Reck

LungenClinic Grosshansdorf

Publications: 147

Kazuhiko Nakagawa

Kazuhiko Nakagawa

Kindai University

Publications: 112

David R. Gandara

David R. Gandara

University of California, Davis

Publications: 112

Rafael Rosell

Rafael Rosell

Autonomous University of Barcelona

Publications: 104

Silvia Novello

Silvia Novello

University of Turin

Publications: 96

Federico Cappuzzo

Federico Cappuzzo

Azienda Unità Sanitaria Locale Della Romagna

Publications: 95

Tony Mok

Tony Mok

Chinese University of Hong Kong

Publications: 93

Roy S. Herbst

Roy S. Herbst

Yale University

Publications: 93

Caicun Zhou

Caicun Zhou

Tongji University

Publications: 89

Yi-Long Wu

Yi-Long Wu

Guangdong Provincial People’s Hospital

Publications: 89

Enriqueta Felip

Enriqueta Felip

Vall d'Hebron Institut de Recerca

Publications: 88

Benjamin Besse

Benjamin Besse

University of Paris-Saclay

Publications: 88

Fred R. Hirsch

Fred R. Hirsch

Mount Sinai Hospital

Publications: 87

Luis Paz-Ares

Luis Paz-Ares

Complutense University of Madrid

Publications: 86

Myung-Ju Ahn

Myung-Ju Ahn

Sungkyunkwan University

Publications: 82

Natasha B. Leighl

Natasha B. Leighl

Princess Margaret Cancer Centre

Publications: 82

Trending Scientists

Donghui Long

Donghui Long

East China University of Science and Technology

Reimund P. Rötter

Reimund P. Rötter

University of Göttingen

Randal W. Beard

Randal W. Beard

Brigham Young University

James E. Maynard

James E. Maynard

Centers for Disease Control and Prevention

Klaus Schughart

Klaus Schughart

Helmholtz Centre for Infection Research

Michael Koch

Michael Koch

University of Bremen

Brent R. Stockwell

Brent R. Stockwell

Columbia University

Alastair H. F. Robertson

Alastair H. F. Robertson

University of Edinburgh

Georg Stoecklin

Georg Stoecklin

Heidelberg University

Marcel Tijsterman

Marcel Tijsterman

Leiden University Medical Center

Paul D. Griffiths

Paul D. Griffiths

University College London

Richard P. Stanley

Richard P. Stanley

MIT

James R. Andrews

James R. Andrews

American Sports Medicine Institute

Matthias Christandl

Matthias Christandl

University of Copenhagen

Neil D. Tsutsui

Neil D. Tsutsui

University of California, Berkeley

Stephen J. Page

Stephen J. Page

University of Hertfordshire

Related Medicine Rankings & Guides

2026 Most Affordable Online Licensed Practical Nurse (LPN) Programs

2026 Most Affordable Online Licensed Practical Nurse (LPN) Programs
2026 Best Nursing Schools in Virginia – Accredited ADN, BSN, MSN Programs

2026 Best Nursing Schools in Virginia – Accredited ADN, BSN, MSN Programs
2026 Healthcare Degree Programs You Can Earn in 2 Years or Less

2026 Healthcare Degree Programs You Can Earn in 2 Years or Less
August 2026 Best Online Certificate Programs in Medical Billing & Coding Programs

August 2026 Best Online Certificate Programs in Medical Billing & Coding Programs
2026 Most Affordable Online Health Information Management Degree Programs

2026 Most Affordable Online Health Information Management Degree Programs
2026 Most Affordable Online Associate’s Degree in Radiology

2026 Most Affordable Online Associate’s Degree in Radiology
August 2026 Best Online Doctorate in Healthcare Management Programs

August 2026 Best Online Doctorate in Healthcare Management Programs
2026 Fastest Online Pharmacy Technician Certificate Programs

2026 Fastest Online Pharmacy Technician Certificate Programs
2026 Easiest Medical Degree Programs

2026 Easiest Medical Degree Programs
2026 Most Affordable Online Medical Assistant Programs

2026 Most Affordable Online Medical Assistant Programs
2026 Best Nurse Practitioner Programs in Florida – Accredited Schools Online & Campus

2026 Best Nurse Practitioner Programs in Florida – Accredited Schools Online & Campus
2026 Most Affordable Online FNP Programs

2026 Most Affordable Online FNP Programs
2026 Best Occupational Therapy Programs

2026 Best Occupational Therapy Programs
2026 Best Online Associate in Physical Therapy Assistant Programs

2026 Best Online Associate in Physical Therapy Assistant Programs
2026 Easiest Accelerated BSN Programs to Get Into

2026 Easiest Accelerated BSN Programs to Get Into
2026 Best Online DNP Programs

2026 Best Online DNP Programs
2026 Best Shortest Online PMHNP Certificate Programs

2026 Best Shortest Online PMHNP Certificate Programs
2026 Most Affordable LPN/LVN to BSN Online Bridge Programs

2026 Most Affordable LPN/LVN to BSN Online Bridge Programs
2026 Best Online Medical & Healthcare Certificate Programs

2026 Best Online Medical & Healthcare Certificate Programs
2026 Most Affordable Online Dental Assistant to Dental Hygienist Bridge Programs

2026 Most Affordable Online Dental Assistant to Dental Hygienist Bridge Programs
2026 Best Shortest Online MSN Programs

2026 Best Shortest Online MSN Programs

Recently Published Articles

2026 Simmons University Online Master of Social Work (MSW) - Traditional: Cost, Admissions, Curriculum, and Career Paths

2026 Simmons University Online Master of Social Work (MSW) - Traditional: Cost, Admissions, Curriculum, and Career Paths
2026 Credit Requirements for an Industrial Organizational Psychology Degree Explained

2026 Credit Requirements for an Industrial Organizational Psychology Degree Explained
2026 Competency-Based Online Health Informatics Master's Degrees

2026 Competency-Based Online Health Informatics Master's Degrees
2026 What Can You Do With a Bioinformatics Degree?

2026 What Can You Do With a Bioinformatics Degree?
2026 Cheapest and Shortest Online Game Programming Degree Programs That Pay Well: Cost, Duration, and Salary Outlook

2026 Cheapest and Shortest Online Game Programming Degree Programs That Pay Well: Cost, Duration, and Salary Outlook
2026 Cheapest Online Colleges & Degree Programs

2026 Cheapest Online Colleges & Degree Programs
2026 Online Exercise & Sports Science Bachelor's Degree Programs Under $10,000

2026 Online Exercise & Sports Science Bachelor's Degree Programs Under $10,000
2026 Best Online User Experience Degree Master's Programs for Working Professionals

2026 Best Online User Experience Degree Master's Programs for Working Professionals
2026 Best Online MSN in Health/Nursing Informatics Programs

2026 Best Online MSN in Health/Nursing Informatics Programs
2026 How to Become a Certified Financial Planner in Illinois

2026 How to Become a Certified Financial Planner in Illinois
2026 Online Finance Degree Master's Programs with No GRE or GMAT Requirements

2026 Online Finance Degree Master's Programs with No GRE or GMAT Requirements
2026 Is Demand for Political Science Degree Graduates Growing or Declining?

2026 Is Demand for Political Science Degree Graduates Growing or Declining?
2026 Best LPN Programs in North Carolina – Accredited Online LPN Programs

2026 Best LPN Programs in North Carolina – Accredited Online LPN Programs
2026 Best Accelerated Online Speech Pathology Degree Programs

2026 Best Accelerated Online Speech Pathology Degree Programs
2026 Master's in Health Informatics Salary

2026 Master's in Health Informatics Salary
2026 LPC Counseling Licensure Requirements in Minnesota

2026 LPC Counseling Licensure Requirements in Minnesota
2026 How to Become a Dermatologist Assistant: Education, Salary, and Job Outlook

2026 How to Become a Dermatologist Assistant: Education, Salary, and Job Outlook
2026 Most Affordable Online Real Estate Degree Programs

2026 Most Affordable Online Real Estate Degree Programs
2026 Best Online MBA Programs With Transfer Credits Accepted

2026 Best Online MBA Programs With Transfer Credits Accepted
2026 Online Artificial Intelligence Degree Master's Programs with No GRE or GMAT Requirements

2026 Online Artificial Intelligence Degree Master's Programs with No GRE or GMAT Requirements
2026 Best Online Master's Degree in Management Information Systems

2026 Best Online Master's Degree in Management Information Systems